ENHANCED INFLAMMATION IN SUBGROUPS OF METABOLIC SYNDROME IRRESPECTIVE OF GLYCAEMIC STATUS

The objectives of this study were toinvestigate the inflammation and endothelial activation biomarkers in subjects with metabolic syndrome (MS)subgroups irrespective of glycaemic status. Subjects (n=319) were categorized into MS subgroups [diabetes mellitus (MSDM), impaired fastig glucose (MSIFG) an...

Full description

Bibliographic Details
Main Authors: Ismai, Z (Author), Nasir, NM (Author), Nawawi, HM (Author), Osman, MT (Author), Rahman, T (Author), Ramli, AS (Author), Razak, SA (Author), Saimin, H (Author)
Format: Article
Language:English
Published: 2017
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02001nam a2200373Ia 4500
001 10.4314-jfas.v9i6s.26
008 220223s2017 CNT 000 0 und d
245 1 0 |a ENHANCED INFLAMMATION IN SUBGROUPS OF METABOLIC SYNDROME IRRESPECTIVE OF GLYCAEMIC STATUS 
260 0 |c 2017 
856 |z View Fulltext in Publisher  |u https://doi.org/10.4314/jfas.v9i6s.26 
520 3 |a The objectives of this study were toinvestigate the inflammation and endothelial activation biomarkers in subjects with metabolic syndrome (MS)subgroups irrespective of glycaemic status. Subjects (n=319) were categorized into MS subgroups [diabetes mellitus (MSDM), impaired fastig glucose (MSIFG) and normoglycemia (MSNG)] and normal controls (NC). Inflammatory biomarkers (high-sensitivity C-reactive protein and interleukin-6) and endothelial activation (soluble intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin) were measured and compared between the groups.MS subjects had significant increase in all biomarkers compared to NC subjects. Glycaemic status in MS subgroups did not show any association with the quartiles of all biomarkers, except for interleukin-6. This may partially explain their increased coronary risk. 
650 0 4 |a ADIPONECTIN 
650 0 4 |a CARDIOVASCULAR-DISEASE 
650 0 4 |a CIRCULATING ADHESION MOLECULES 
650 0 4 |a COMPLICATIONS 
650 0 4 |a C-REACTIVE PROTEIN 
650 0 4 |a DIABETIC-NEPHROPATHY 
650 0 4 |a endothelial activation 
650 0 4 |a glycaemic status 
650 0 4 |a inflammation 
650 0 4 |a INSULIN-RESISTANCE 
650 0 4 |a MARKERS 
650 0 4 |a metabolic syndrome 
650 0 4 |a MORTALITY 
650 0 4 |a RISK 
700 1 0 |a Ismai, Z  |e author 
700 1 0 |a Nasir, NM  |e author 
700 1 0 |a Nawawi, HM  |e author 
700 1 0 |a Osman, MT  |e author 
700 1 0 |a Rahman, T  |e author 
700 1 0 |a Ramli, AS  |e author 
700 1 0 |a Razak, SA  |e author 
700 1 0 |a Saimin, H  |e author 
773 |t JOURNAL OF FUNDAMENTAL AND APPLIED SCIENCES  |g 9, 331-349